Testing effectiveness (Phase 2)UnknownNCT00003827What this trial is testingCombination Chemotherapy in Treating Patients With Myelodysplastic SyndromeWho this might be right forLeukemiaMyelodysplastic Syndromes ALZA 25
Not applicableUnknownNCT00295997What this trial is testingDonor Stem Cell Transplant in Treating Patients With Hematologic Cancer, Metastatic Kidney Cancer, or Aplastic AnemiaWho this might be right forChronic Myeloproliferative DisordersKidney CancerLeukemia+4 more University of California, San Francisco 35
Testing effectiveness (Phase 2)Active Not RecruitingNCT01522976What this trial is testingAzacitidine With or Without Lenalidomide or Vorinostat in Treating Patients With Higher-Risk Myelodysplastic Syndromes or Chronic Myelomonocytic LeukemiaWho this might be right forChronic Myelomonocytic LeukemiaChronic Myelomonocytic Leukemia-1Chronic Myelomonocytic Leukemia-2+4 more National Cancer Institute (NCI) 282
Early research (Phase 1)Study completedNCT01139151What this trial is testing4'-Thio-araC (Thiarabine) in Advanced Hematologic MalignanciesWho this might be right forLeukemia M.D. Anderson Cancer Center 31
Early research (Phase 1)Study completedNCT00891137What this trial is testingSafety Study of Human Myeloid Progenitor Cells (CLT-008) After Cord Blood Transplant for Hematologic MalignancyWho this might be right forLeukemiaLymphomaMultiple Myeloma+2 more Cellerant Therapeutics 30
Testing effectiveness (Phase 2)Study completedNCT00975975What this trial is testingBasiliximab #2: In-Vivo Activated T-Cell Depletion to Prevent Graft-Versus_Host Disease (GVHD) After Nonmyeloablative Allotransplantation for the Treatment of Blood CancerWho this might be right forAcute Myelogenous LeukemiaAcute Lymphocytic LeukemiaChronic Myelogenous Leukemia+8 more Indiana University 17
Testing effectiveness (Phase 2)Study completedNCT00352001What this trial is testingLenalidomide and Azacitidine in Treating Patients With Advanced Myelodysplastic SyndromesWho this might be right forLeukemiaMyelodysplastic Syndromes Mikkael Sekeres MD 37
Not applicableStudy completedNCT04629430What this trial is testingEffects of Prebiotics on Gut Microbiome in Patients Undergoing HSCTWho this might be right forMultiple MyelomaAcute Myeloid LeukemiaAcute Lymphoblastic Leukemia+9 more University of Virginia 40
Not applicableStudy completedNCT05260203What this trial is testingMargheRITA (Remote Intelligence for Therapeutic Adherence)Who this might be right forMultiple MyelomaSolitary PlasmacytomaAmyloidosis+11 more Advice Pharma Group srl 124
Testing effectiveness (Phase 2)UnknownNCT02007811What this trial is testingOpen-label Clinical Trial to Investigate the Safety and Tolerability of Allogeneic B-cell Concentrates for Immune Reconstitution After Allogeneic Stem Cell Transplantation Measured as Response to a Antedated Single VaccinationWho this might be right forAcute Myeloid LeukemiaAcute Lymphoblastic LeukemiaChronic Myeloid Leukemia+5 more University of Erlangen-Nürnberg Medical School 15
Large-scale testing (Phase 3)Study completedNCT04060264What this trial is testingClinical Trial of BCD-148 and Soliris® for the Treatment of Patients With Paroxysmal Nocturnal HemoglobinuriaWho this might be right forParoxysmal Nocturnal Hemoglobinuria Biocad 28
Testing effectiveness (Phase 2)Study completedNCT06051357What this trial is testingProof of Concept Study to Assess the Efficacy, Safety of HRS-5965 in Patients With Paroxysmal Nocturnal HemoglobinuriaWho this might be right forParoxysmal Nocturnal Hemoglobinuria Chengdu Suncadia Medicine Co., Ltd. 26
Early research (Phase 1)Study completedNCT04439006What this trial is testingIbrutinib for the Treatment of COVID-19 in Patients Requiring HospitalizationWho this might be right forAplastic AnemiaHematopoietic and Lymphoid Cell NeoplasmMalignant Solid Neoplasm+4 more Jennifer Woyach 10
Early research (Phase 1)Study completedNCT06326814What this trial is testingTest if SAR443809 is Tolerated and Safe When Taken as a Single Dose in Healthy AdultsWho this might be right forParoxysmal Nocturnal Hemoglobinuria Sanofi 54
Early research (Phase 1)Ended earlyNCT00234000What this trial is testingAzacitidine and Arsenic Trioxide in Treating Patients With Myelodysplastic SyndromesWho this might be right forLeukemiaMyelodysplastic Syndromes Jonsson Comprehensive Cancer Center 1
Testing effectiveness (Phase 2)Looking for participantsNCT07187401What this trial is testingA First-in-Human Safety and Efficacy Study of ALN-CFB, a Small Interfering RNA (siRNA) Targeting Complement Factor B, in Adult Participants With Paroxysmal Nocturnal Hemoglobinuria With Persistent Anemia on a C5 InhibitorWho this might be right forParoxysmal Nocturnal Hemoglobinuria (PNH)Persistent Anemia Regeneron Pharmaceuticals 24
Large-scale testing (Phase 3)Study completedNCT00004208What this trial is testingAntithymocyte Globulin and Cyclosporine in Treating Patients With Myelodysplastic SyndromeWho this might be right forMyelodysplastic Syndromes Swiss Cancer Institute 86
Early research (Phase 1)Study completedNCT00015925What this trial is testingMS-275 in Treating Patients With Hematologic CancerWho this might be right forLeukemiaMultiple Myeloma and Plasma Cell NeoplasmMyelodysplastic Syndromes+1 more Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Testing effectiveness (Phase 2)Study completedNCT00413114What this trial is testingSafety and Efficacy of Obatoclax Mesylate (GX15-070MS)for the Treatment of Myelodysplastic Syndromes (MDS)Who this might be right forMyelodysplastic Syndromes Gemin X 24
Testing effectiveness (Phase 2)Study completedNCT01192399What this trial is testingSafety and Efficacy Study of Eculizumab in Paroxysmal Nocturnal Hemoglobinuria PatientsWho this might be right forParoxysmal Nocturnal Hemoglobinuria Alexion Pharmaceuticals, Inc. 29